Axsome Therapeutics’ Auvelity expanded its label to include treating agitation in Alzheimer’s disease patients. It’s just the second FDA-approved drug for this indication, and Axsome’s pill has a safety advantage. The post Axsome Drug’s FDA Approval Unlocks New Opportunity in Alzheimer’s Agitation appeared first on MedCity News.
A team of researchers concludes that Medicare Part D coverage of weight-loss drugs could explode costs
A document the Department of Health and Human Services sent to lawmakers to support Secretary Robert F. Kennedy Jr.’s decision to change U.S. policy on covid vaccines cites scientific studies that are unpublished or under dispute and mischaracterizes others. One health expert called the document “willful medical disinformation” about the safety of covid vaccines for…
Blue Shield of California Promise Health Plan has launched a program that gives eligible new parents in San Diego County baby supplies and incentives to support postpartum and infant care. The post Blue Shield of California Plan Introduces Initiative to Support Expecting Parents appeared first on MedCity News.
MINNEAPOLIS. — Gabi tiene grandes ojos color café, trenzas y una afección genética que hace que sus huesos sean frágiles. Se fracturan con facilidad, lo que le provoca a la niña de 2 años tanto dolor que su madre dejó su trabajo limpiando oficinas para quedarse en casa y cargarla por el apartamento de una…
Without trust, the rapid adoption of AI in healthcare could stall, pointed out Joel Gordon, UW Health’s chief medical information officer. He urged healthcare leaders to focus less on flashy rollouts and more on governance, collaboration, and meaningful metrics to ensure AI delivers lasting value. The post Don’t Let the Floor Fall Out From Under…
Pfizer unveiled a multi-drug R&D collaboration with Innovent Biologics, making it the latest big pharma company to reach a deal that taps into Chinese labs to source biotech innovation. This alliance will focus on developing next-generation drugs in the class of targeted cancer therapies called antibody drug conjugates. The post Pfizer’s $10.5B Deal With One…
Impact Primary Care Network selected Innovaccer for its unified platform supporting care management and population health analytics
How best can you design an outcomes based agreement (OBA)? What are the key factors to consider? Project IDEATE is a “cross-disciplinary collaboration between National Health Service (NHS) Wales, industry and academia” with the aim to develop and refine OBA models. What were the key factors IDEATE considered for an OBA? Feasibility: Identify parameters to…
Direct-to-patient (DTP) models create a continuous loop of value, connecting seamless patient and provider experience with the strategic power of branding and data. The post The Brand-Driven Flywheel: Igniting Growth Through a Simple Patient Experience appeared first on MedCity News.